(IN BRIEF) From 16–19 July, Liverpool hosted the IAOO’s 10th World Congress at ACC Liverpool, attracting over a thousand delegates from 55 countries. Organised by University of Liverpool experts and supported by Liverpool City Council, the congress focused on oral … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Science, Technology, United Kingdom
Tagged ACC Liverpool, Dr Caroline McCarthy, early diagnosis, head and neck cancers, IAOO, Institute of Systems Molecular and Integrative Biology, International Academy of Oral Oncology, Liverpool, Liverpool City Council, Liverpool Diagnostic Infrared Wand, Liverpool Head & Neck Centre, Machine Learning, oral cancer, prevention, Professor Andrew Schache, Professor Chris Butterworth, Professor Christian Ottensmeier, Professor Jo Patterson, Professor Matt Ashton, Professor Richard Shaw, Survivorship, treatment, University of Liverpool
(IN BRIEF) Roche’s ongoing Phase Ib/IIa Brainshuttle™ AD study of trontinemab shows that 91 percent of participants reach amyloid PET negativity, with ARIA‑E rates under 5 percent. The company has outlined Phase III TRONTIER 1 and 2 trials in early symptomatic Alzheimer’s for 2025, plus a planned … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Alzheimer’s Association International Conference, amyloid plaques, amyloid‑beta monoclonal antibody, ARIA‑E, blood‑based biomarker, blood‑brain barrier, Brainshuttle, centiloids, clinical dementia rating sum of boxes, cognitive decline, diagnostics, early diagnosis, Elecsys pTau217, Levi Garraway, Matt Sause, PET negativity, Phase Ib/IIa, Phase III TRONTIER 1, Phase III TRONTIER 2, preclinical Alzheimer’s, pTau181, pTau217/Ab42 ratio, Roche, sustainability of clinical trials, TRAVELLER, trontinemab
(IN BRIEF) Boehringer Ingelheim and Eko Health have partnered to launch a canine-specific heart murmur detection solution in 2026. Leveraging Boehringer’s veterinary cardiology insights and proprietary algorithm alongside Eko’s AI-enabled digital stethoscopes and mobile app, the tool will help veterinarians … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged AI algorithm, Boehringer Ingelheim, canine cardiology, Connor Landgraf, digital stethoscope, Dr. Erich Schött, early diagnosis, Eko Health, heart murmur detection, MMVD, mobile app, myxomatous mitral valve disease, partnership, pet health, veterinary innovation
(IN BRIEF) A team of researchers from the University of Copenhagen has revealed groundbreaking findings about insulin resistance, showing that it varies widely on a molecular level even among healthy individuals and those diagnosed with type 2 diabetes. This discovery … Read the full press release
Posted in Business, Denmark, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged Anna Krook, Atul Deshmukh, diabetes research, early diagnosis, insulin resistance, Jeppe Kjærgaard Northcote, Karolinska Institutet, molecular signatures, muscle tissue, personalized treatments, precision medicine, proteomics, Steno Diabetes Center, type 2 diabetes, University of Copenhagen
(IN BRIEF) A landmark international study has provided robust evidence that elevated levels of prolactin, a hormone involved in breast development, increase the risk of breast cancer in post-menopausal women. Researchers from The Institute of Cancer Research in London, along … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged B2Risk consortium, BMI, breast cancer, Breast Cancer Now, cohort studies, Dr Simon Vincent, early diagnosis, ICR, Institute of Cancer Research, invasive breast cancer, mammographic density, personalized prevention, plasma levels, PMH, polygenic risk score, post-menopausal, Professor Montse Garcia-Closas, prolactin, risk factor, targeted interventions
(IN BRIEF) The University of Exeter has developed a new algorithm for interpreting blood test results, helping GPs detect potential cancer warning signs earlier, particularly through variations in platelet count. The Royal Devon University Healthcare NHS Foundation Trust is the … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged algorithm, Australia, blood test, bowel cancer, CANADA, Cancer Detection, Cancers journal, David Walton, Devon, early diagnosis, early warning signs, England, Exeter HealthTech Research Centre, general practitioners, GP, High or Elevated Level of Platelets (HELP) Flag, lung cancer, medical research, National Institute for Health and Care Research, NHS, patient outcomes, personalized thresholds, platelet count, platelet variation, Professor Sarah Bailey, RDUH, Royal Devon University Healthcare NHS Foundation Trust, University of Exeter
(IN BRIEF) A groundbreaking study led by researchers from the University of Exeter, the Wellcome Sanger Institute, and the University of Cambridge introduces a novel approach to genetic testing, potentially revolutionizing the diagnosis of rare developmental disorders in children. By … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Caroline Wright, Children with Rare Disorders, early diagnosis, Helen Firth, partnership, Professor Matthew Hurles, Single Genetic Test, sustainability, University of Cambridge, University of Exeter, Wellcome Sanger Institute
Experts present lessons learned from past control programs and new approaches to eliminating diseases such as leprosy and malaria. The Novartis Foundation for Sustainable Development (NFSD) launches a new strategy to help eliminate leprosy. For over 15 years, the annual symposium of … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?